Phenytoin-induced cerebellar atrophy in an epileptic boy

Area of Science:

• Neurology
• Pediatrics
• Clinical Toxicology

Background:

• Epilepsy affects many children, with phenytoin sodium being a common treatment.
• Phenytoin has a narrow therapeutic range and significant pharmacokinetic variability, increasing the risk of toxicity.
• Cerebellar atrophy is a potential, though uncommon, adverse effect of antiepileptic drugs.

Observation:

• A 16-year-old boy with epilepsy presented with a viral infection.
• The patient was receiving long-term treatment with phenytoin sodium.
• Neurological examination revealed signs suggestive of cerebellar dysfunction.

Findings:

• Cerebellar atrophy was diagnosed in the patient.
• The atrophy was attributed to phenytoin toxicity.
• This case underscores the importance of monitoring for neurotoxicity in patients on long-term phenytoin therapy.

Implications:

• This case highlights a rare but serious adverse effect of phenytoin, emphasizing the need for careful patient monitoring.
• Clinicians should consider phenytoin-induced neurotoxicity in epileptic patients presenting with cerebellar symptoms.
• Further research into the long-term effects and optimal dosing of phenytoin in pediatric epilepsy is warranted.